A blood-based signature of neocortical amyloid burden : an early diagnostic population screening tool for Alzheimer's disease
Alzheimer´s disease (AD) biomarkers that can detect and track disease progression at its earliest stages to aid the critical search for a disease modifying therapy is much needed. Markers of in vivo amyloid-beta (Aβ) deposition (e.g. 11C-PiB) combined with positron emission tomography (PET) or cereb...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.724288 |